IMTX
Immatics N.V.NASDAQHealthcare$10.35+3.40%ClosedMarket Cap: $1.39B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.33
P/S
24.80
EV/EBITDA
-4.49
DCF Value
$-2.22
FCF Yield
-15.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-371.6%
Net Margin
-390.9%
ROE
-39.7%
ROA
-33.6%
ROIC
-34.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $19.8M | 100.0% | $-36.2M | $-27.9M | $-0.28 | — |
| FY 2025 | $48.3M | 100.0% | $-179.4M | $-188.7M | $-1.54 | — |
| Q3 2025 | $5.2M | 100.0% | $-54.6M | $-50.5M | $-0.42 | — |
| Q2 2025 | $4.7M | 100.0% | $-53.1M | $-70.3M | $-0.58 | — |
| Q1 2025 | $18.6M | 100.0% | $-35.4M | $-39.9M | $-0.33 | — |
| Q4 2024 | $56.3M | 100.0% | $903.0K | $44.9M | $0.46 | — |
| FY 2024 | $155.8M | 100.0% | $-38.6M | $15.2M | $0.14 | — |
| Q3 2024 | $50.6M | 100.0% | $514.0K | $-8.6M | $-0.11 | — |
| Q2 2024 | $18.8M | 99.5% | $-26.6M | $-18.0M | $-0.17 | — |
| Q1 2024 | $30.4M | -5.5% | $-13.6M | $-3.1M | $-0.03 | — |
| Q4 2023 | $15.9M | -109.0% | $-27.7M | $-26.1M | $-0.31 | — |
| FY 2023 | $54.0M | -119.8% | $-101.7M | $-97.0M | $-1.20 | — |